Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
NCT03968328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315
Last updated 2023-07-21
Summary
This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause specific death, intensive care unit admission, hospital length of stay, and positive blood cultures.
Conditions
Interventions
- OTHER
-
Interview
Take part in interview
- OTHER
-
Survey Administration
Respond to survey
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Sai-ching Yeung, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-19
- Primary Completion
- 2023-01-17
- Completion
- 2023-01-17
Countries
- United States
Study Locations
More Related Trials
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
NCT00335478 ·Status: COMPLETED ·Phase: PHASE2
-
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
NCT00020865 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
NCT00190463 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522 ·Status: RECRUITING
-
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
NCT00445497 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
NCT04000711 ·Status: COMPLETED ·Phase: NA
-
Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
NCT02463747 ·Status: UNKNOWN ·Phase: PHASE4
-
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
NCT04081753 ·Status: COMPLETED ·Phase: NA
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
NCT05793073 ·Status: COMPLETED
-
Short Antibiotic Treatment in High Risk Febrile Neutropenia
NCT05786495 ·Status: RECRUITING ·Phase: NA
-
Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
NCT00003739 ·Status: COMPLETED ·Phase: PHASE3
-
Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
NCT04557709 ·Status: WITHDRAWN
-
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia
NCT03449693 ·Status: UNKNOWN ·Phase: PHASE2
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
NCT03530072 ·Status: COMPLETED
-
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
NCT02805205 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study
NCT01763398 ·Status: COMPLETED
-
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
NCT03793205 ·Status: UNKNOWN ·Phase: PHASE4
-
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
NCT04101760 ·Status: UNKNOWN ·Phase: PHASE3
-
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
NCT02728596 ·Status: COMPLETED ·Phase: NA
-
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
NCT01813721 ·Status: COMPLETED